Mast Therapeutics, Inc. (NYSE MKT:MSTX), announced that it will hold a conference call at 8am Eastern Time, 5am Pacific Time on Tuesday, January 6, 2015. The Company intends to provide an update on EPIC, its pivotal phase 3 study of its lead product candidate vepoloxamer (MST-188) in sickle cell disease, which the Company continues to expect will complete enrollment by the end of 2015, and … Continue reading Stocks in news: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Whiting Petroleum Corp. (NYSE:WLL), Bebe Stores, Inc. (NASDAQ:BEBE), Mallinckrodt PLC (NYSE:MNK), Intervest Bancshares Corp. (NASDAQ:IBCA)